NIM
NEOS Investment Management Portfolio holdings
AUM
$8.08B
This Quarter Return
+5.84%
1 Year Return
+24.46%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$3.31B
AUM Growth
+$3.31B
(+36%)
Cap. Flow
+$835M
Cap. Flow
% of AUM
25.23%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
588
New
19
Increased
514
Reduced
16
Closed
9
Top Buys
| 1 |
Broadcom
AVGO
|
$67.9M |
| 2 |
Vanguard Russell 2000 ETF
VTWO
|
$64.4M |
| 3 |
Apple
AAPL
|
$36.2M |
| 4 |
Microsoft
MSFT
|
$35.6M |
| 5 |
NVIDIA
NVDA
|
$34.7M |
Top Sells
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$1.21M |
| 2 |
Super Micro Computer
SMCI
|
$812K |
| 3 |
Exelixis
EXEL
|
$572K |
| 4 |
MREO
Mereo BioPharma
MREO
|
$511K |
| 5 |
Vale
VALE
|
$440K |
Sector Composition
| 1 | Technology | 32.75% |
| 2 | Healthcare | 12.38% |
| 3 | Communication Services | 9.77% |
| 4 | Consumer Discretionary | 9.17% |
| 5 | Industrials | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Devon Energy
DVN
$22.3B
| $1.1M | 0.03% |
28,182
+5,684
| +25% | +$222K |
|
352
State Street
STT
$31.9B
| $1.1M | 0.03% |
12,545
+2,436
| +24% | +$214K |
|
353
TransDigm Group
TDG
$73.5B
| $1.1M | 0.03% |
771
| – | – |
|
354
Day One Biopharmaceuticals
DAWN
$764M
| $1.1M | 0.03% |
78,883
+14,030
| +22% | +$195K |
|
355
CRISPR Therapeutics
CRSP
$4.82B
| $1.1M | 0.03% |
23,323
+5,387
| +30% | +$253K |
|
356
Cencora
COR
$57B
| $1.09M | 0.03% |
4,836
+812
| +20% | +$183K |
|
357
Weyerhaeuser
WY
$17.9B
| $1.09M | 0.03% |
32,115
+6,496
| +25% | +$220K |
|
358
Eversource Energy
ES
$23.5B
| $1.08M | 0.03% |
15,864
+3,248
| +26% | +$221K |
|
359
DTE Energy
DTE
$28.1B
| $1.08M | 0.03% |
8,380
+1,624
| +24% | +$209K |
|
360
Nuvalent
NUVL
$5.64B
| $1.07M | 0.03% |
10,477
+660
| +7% | +$67.5K |
|
361
Terns Pharmaceuticals
TERN
$642M
| $1.07M | 0.03% |
128,305
-36,916
| -22% | -$308K |
|
362
PPL Corp
PPL
$26.8B
| $1.07M | 0.03% |
32,285
+6,496
| +25% | +$215K |
|
363
AvalonBay Communities
AVB
$27.1B
| $1.06M | 0.03% |
4,723
+812
| +21% | +$183K |
|
364
Exact Sciences
EXAS
$9.22B
| $1.06M | 0.03% |
15,614
-5,128
| -25% | -$349K |
|
365
Teradyne
TER
$19B
| $1.06M | 0.03% |
7,907
+1,662
| +27% | +$223K |
|
366
First Solar
FSLR
$21.7B
| $1.06M | 0.03% |
4,240
+812
| +24% | +$203K |
|
367
Madrigal Pharmaceuticals
MDGL
$9.57B
| $1.06M | 0.03% |
4,978
+380
| +8% | +$80.6K |
|
|
368
Exelixis
EXEL
$9.93B
| $1.05M | 0.03% |
40,582
-22,041
| -35% | -$572K |
|
369
FirstEnergy
FE
$25B
| $1.05M | 0.03% |
23,679
+4,872
| +26% | +$216K |
|
370
Ventas
VTR
$30.7B
| $1.05M | 0.03% |
16,428
+3,248
| +25% | +$207K |
|
371
NetApp
NTAP
$23.2B
| $1.04M | 0.03% |
8,407
+1,624
| +24% | +$201K |
|
372
Agios Pharmaceuticals
AGIO
$2.35B
| $1.03M | 0.03% |
23,208
+1,463
| +7% | +$65K |
|
373
SBA Communications
SBAC
$21.7B
| $1.02M | 0.03% |
4,245
+812
| +24% | +$195K |
|
374
Regions Financial
RF
$23.9B
| $1.01M | 0.03% |
43,168
+8,932
| +26% | +$208K |
|
375
Genmab
GMAB
$16.6B
| $1M | 0.03% |
41,150
+2,596
| +7% | +$63.3K |
|